These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Nocardia farcinica infection in a patient with cystic fibrosis]. Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956 [TBL] [Abstract][Full Text] [Related]
23. Possible activation of an intramyocardial inflammatory process ( Staphylococcus aureus)after treatment with infliximab in a boy with Crohn disease. Reichardt P; Dähnert I; Tiller G; Häusler HJ Eur J Pediatr; 2002 May; 161(5):281-3. PubMed ID: 12012225 [TBL] [Abstract][Full Text] [Related]
24. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy]. Joosten AA; van Olffen GH; Hageman G Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1470-2. PubMed ID: 12908351 [TBL] [Abstract][Full Text] [Related]
25. [Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients]. de Ridder L; Escher JC; Taminiau JA Ned Tijdschr Geneeskd; 2002 Oct; 146(40):1879-83. PubMed ID: 12395595 [TBL] [Abstract][Full Text] [Related]
26. An uncommon cause of abdominal pain and fever in a patient with Crohn's disease. Wysocki JD; Said SM; Papadakis KA Gastroenterology; 2015 May; 148(5):e12-3. PubMed ID: 25824348 [No Abstract] [Full Text] [Related]
27. Tracheitis as the Initial Presentation of Crohn's Disease. Wolfe A; Lee TJ; Gillespie CT; Rao S; Walter JM Am J Respir Crit Care Med; 2021 Mar; 203(5):e9-e10. PubMed ID: 33096005 [No Abstract] [Full Text] [Related]
28. Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease. Kierkuś J; Iwańczak B; Wegner A; Dadalski M; Grzybowska-Chlebowczyk U; Łazowska I; Maślana J; Toporowska-Kowalska E; Czaja-Bulsa G; Mierzwa G; Korczowski B; Czkwianianc E; Żabka A; Szymańska E; Krzesiek E; Więcek S; Sładek M J Pediatr Gastroenterol Nutr; 2015 May; 60(5):580-5. PubMed ID: 25564804 [TBL] [Abstract][Full Text] [Related]
29. [Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFalpha) therapy]. Salavert M; Bastida G; Pemán J; Nos P Rev Iberoam Micol; 2009 Sep; 26(3):213-7. PubMed ID: 19635442 [TBL] [Abstract][Full Text] [Related]
30. Rapidly developed neurosyphilis in a psoriasis patient under treatment with infliximab: a case report. Kase K; Ishii-Osai Y; Sumikawa Y; Yoneta A; Himeno D; Kakutani Y; Yamashita T Acta Derm Venereol; 2015 Mar; 95(3):351-2. PubMed ID: 25111397 [No Abstract] [Full Text] [Related]
32. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340 [TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051 [TBL] [Abstract][Full Text] [Related]
34. [The occurrence of purulent hyperscretion in bronchiectasis and chronic bronchitis (author's transl)]. Wendel H Z Erkr Atmungsorgane; 1974; 141(2):169-74. PubMed ID: 4458292 [No Abstract] [Full Text] [Related]
35. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Maser EA; Villela R; Silverberg MS; Greenberg GR Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170 [TBL] [Abstract][Full Text] [Related]
37. Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy. Duron C; Goutte M; Pereira B; Bommelaer G; Buisson A Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):705-11. PubMed ID: 25856689 [TBL] [Abstract][Full Text] [Related]
38. Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study. van der Have M; Belderbos TD; Fidder HH; Leenders M; Dijkstra G; Peters CP; Eshuis EJ; Ponsioen CY; Siersema PD; van Oijen MG; Oldenburg B; Dig Liver Dis; 2014 Oct; 46(10):881-6. PubMed ID: 25081843 [TBL] [Abstract][Full Text] [Related]
39. Salmonella typhimurium osteomyelitis of the femur in patient with Crohn's disease. Gulan G; Jotanovic Z; Jurdana H; Sestan B; Ravlic-Gulan J; Brncic N Wien Klin Wochenschr; 2010 Jul; 122(13-14):437-40. PubMed ID: 20623256 [TBL] [Abstract][Full Text] [Related]